HTH-01-015
HTH-01-015 is a potent, specific NUAK1 (AMPK-related kinase 5, ARK5) inhibitor with IC50 of 100 nM, displays >100-fold higher potency than NUAK2; also does not markedly suppress the activity of any of the other 139 protein kinases, including AMPK; suppresses NUAK1-mediated MYPT1 phosphorylation in vivo, the NUAK1 mutation (A195T) renders resistant to HTH-01-015; significantly inhibits migration the proliferation of MEFs (mouse embryonic fibroblasts) .
Product Specifications
CAS Number
1613724-42-7
Product Name Alternative
HTH 01 015
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
CC1=C (N (C) C (C2=CC (C=CC=C3) =C3C=C2N4C) =O) C4=NC (NC5=CN (N=C5) C6CCNCC6) =N1
Molecular Formula
C26H28N8O
Molecular Weight
468.5535
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
6H-Naphtho[2,3-e]pyrimido[5,4-b][1,4]diazepin-6-one, 5,13-dihydro-4,5,13-trimethyl-2-[[1- (4-piperidinyl) -1H-pyrazol-4-yl]amino]-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ELF3 (E74-like Factor 3 (ets Domain Transcription Factor, Epithelial-Specific), EPR-1, ERT, ESE-1, ESX) (HRP)
ELF3 (E74-like Factor 3 (ets Domain Transcription Factor, Epithelial-Specific), EPR-1, ERT, ESE-1, ESX) (HRP)
ANKRD37, CT (ANKRD37, LPR2BP, Ankyrin repeat domain-containing protein 37, Low-density lipoprotein receptor-related protein 2-binding protein) (AP)
ANKRD37, CT (ANKRD37, LPR2BP, Ankyrin repeat domain-containing protein 37, Low-density lipoprotein receptor-related protein 2-binding protein) (AP)